Director Milton Ault adds Alzamend Neuro (ALZN) shares in open-market buy

Rhea-AI Filing Summary

Alzamend Neuro, Inc. director Milton C. Ault III, through affiliated entities, reported an indirect open-market purchase of 108,388 shares of common stock at $1.0047 per share on April 14, 2026, executed by Ault Lending, LLC.

After this trade, Ault Lending, LLC held 116,648 common shares. Separate indirect holdings disclosed include 11,068 shares held by Ault Life Sciences, Inc. and 61 shares held by Ault Life Sciences Fund, LLC, with Mr. Ault having voting and investment power over these entities’ positions.

Insider Trade Summary

Net Buyer: 108,388 shares ($108,897)

Net Buy 3 txns

Insider AULT MILTON C III

Role Director

Bought 108,388 shs ($109K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	108,388	$1.0047	$109K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 116,648 shares (Indirect, By Ault Lending, LLC)

Footnotes (1)

1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

Key Figures

Open-market purchase: 108,388 shares Purchase price: $1.0047 per share Ault Lending holdings: 116,648 shares +2 more

5 metrics

Open-market purchase 108,388 shares Indirect common stock buy on April 14, 2026

Purchase price $1.0047 per share Price for 108,388 ALZN common shares

Ault Lending holdings 116,648 shares Indirect common shares following transaction

Ault Life Sciences, Inc. holdings 11,068 shares Indirect common shares as of April 14, 2026

Ault Life Sciences Fund, LLC holdings 61 shares Indirect common shares as of April 14, 2026

Key Terms

open-market purchase, indirect ownership, voting and investment power, wholly-owned subsidiary, +1 more

5 terms

open-market purchase financial

"transaction_action: "open-market purchase" for 108,388 common shares"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type: "indirect" and ownership_code: "I" on common stock entries"

voting and investment power financial

"footnotes state Mr. Ault "is deemed to have voting and investment power""

wholly-owned subsidiary financial

"Ault Lending, LLC is described as "a wholly-owned subsidiary" of HSD"

A wholly-owned subsidiary is a company whose entire ownership is held by another company, called the parent, so the parent controls all shares, board appointments and major decisions. For investors this matters because the subsidiary’s profits, losses, assets and liabilities are treated as part of the parent’s financial picture, affecting valuation and risk exposure — imagine a parent owning a single storefront outright and consolidating its receipts and bills into the parent’s books.

common stock financial

"security_title: "Common Stock" for all reported entries"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AULT MILTON C III

(Last) (First) (Middle)

11411 SOUTHERN HIGHLANDS PARKWAY

SUITE 190

(Street)

LAS VEGAS NEVADA 89141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alzamend Neuro, Inc. [ ALZN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/14/2026		P		108,388	A	$1.0047	116,648	I	By Ault Lending, LLC(1)
Common Stock								11,068	I	By Ault Life Sciences, Inc.(2)
Common Stock								61	I	By Ault Life Sciences Fund, LLC(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.

2. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

Remarks:

	By: /s/ Milton C. Ault, III	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alzamend Neuro (ALZN) disclose for Milton C. Ault III?

Alzamend Neuro disclosed that director Milton C. Ault III, via Ault Lending, LLC, made an indirect open-market purchase of 108,388 common shares at $1.0047 per share on April 14, 2026. This filing reflects a net-buy transaction with no reported sales.

At what price were the ALZN shares purchased in Milton Ault’s latest Form 4?

The reported open-market purchase was executed at an average price of $1.0047 per Alzamend Neuro common share. This precise per-share figure comes directly from the Form 4 transaction details for the 108,388 shares acquired indirectly by Ault Lending, LLC.

How many Alzamend Neuro shares does Ault Lending, LLC hold after the reported transaction?

Following the April 14, 2026 purchase, Ault Lending, LLC is shown holding 116,648 Alzamend Neuro common shares. The Form 4 states this as the total number of shares indirectly owned through Ault Lending after the 108,388-share open-market buy.

What other indirect ALZN holdings related to Milton Ault are disclosed in the Form 4?

The Form 4 lists 11,068 Alzamend Neuro shares held by Ault Life Sciences, Inc. and 61 shares held by Ault Life Sciences Fund, LLC. Footnotes state Mr. Ault has sole voting and investment power over securities held by these entities.

Was the Alzamend Neuro (ALZN) Form 4 transaction a buy or sell by entities associated with Milton Ault?

The primary reported transaction is a net-buy. Ault Lending, LLC, associated with director Milton C. Ault III, completed an open-market purchase of 108,388 Alzamend Neuro common shares, with no corresponding sale transactions reported in this Form 4 filing.